Ks. Ronningen et al., ANTI-BSA ANTIBODIES DO NOT CROSS-REACT WITH THE 69-KDA ISLET-CELL AUTOANTIGEN ICA69, Journal of autoimmunity (Print), 11(3), 1998, pp. 223-231
In contrast to several previously published reports, we demonstrate by
a variety of antibody assays that bovine serum albumin (BSA) is not a
ntigenically cross-reactive with the 69-kDa islet cell autoantigen (IC
A69). Fast protein liquid chromatography purified BSA and highly purif
ied recombinant human ICA69 were used to establish sensitive Western b
lot and ELISA assays in order to detect antibodies against these two p
roteins. The assays excluded BSA or powdered milk as blocking agents,
since these would interfere with antibody binding. A panel of sera fro
m diabetic individuals, first degree relatives, and normal controls sh
owed that the majority (similar to 70%) of individuals from each group
had antibodies against ICA69 as assayed by Western blots, whereas con
siderably fewer (similar to 13%) had anti-BSA antibodies on Western bl
ots, and individuals with antibodies to both proteins occurred only ra
rely (2-3%). To explore this issue further we immunized a total of 16
individual rats, representing four different strains (bio-breeding dia
betes resistant and diabetes prone, Wistar-Furth, and Sprague-Dawley),
with either BSA (n=2 of each strain) or with recombinant ICA69 (n=2 o
f each strain), and for each animal pre- and postimmune antibody titre
s against BSA and against ICA69 were assayed separately by enzyme-link
ed immunoabsorbent assay. In rats immunized with BSA, anti-BSA titres
increased about 100,000-fold over preimmune levels, whereas anti-ICA69
reactive antibodies were unchanged over preimmune levels. Similarly,
in rats immunized with ICA69, anti-ICA69 titres rose about 100,000-fol
d over preimmune levels, whereas anti-BSA antibodies were unchanged ov
er preimmune levels. Thus we find no evidence for the existence of ant
ibody cross-reactivity between ICA69 and BSA, either in humans or in i
mmunized rats. When our rat anti-BSA antisera were used to probe Weste
rn blots made from rat islets isolated in the strict absence of fetal
calf serum, we were unable to detect a 69-kDa band, even when the isle
ts were preincubated with gamma-interferon, a treatment which has been
reported to induce the BSA cross-reactive islet antigen. We conclude
that BSA is not antigenically cross-reactive with ICA69 at the antibod
y level, and it is highly unlikely that BSA is antigenically cross-rea
ctive with some other 69 kD islet cell antigen. (C) 1998 Academic Pres
s.